"There is a sense in the markets that there was some overselling last week"
- Lorne Baring, managing director at B Capital SA
Swiss stocks rose on Monday, led by health-care companies. Roche Holding AG, world's largest cancer drugs manufacturer, gained 1.2 per cent.
The Swiss blue-chip index SMI, a measure of the largest and most actively traded companies, gained 0.87%, or 52.79 points, to 6,124.91. The broader Swiss Performance Index advanced 0.58%, or 32.48 points, to 5,627.83.
"There is a sense in the markets that there was some overselling last week," said Lorne Baring, managing director at B Capital SA in Geneva.
"That, along with the focus on the U.S. earnings season, has given the markets a breather. However, it would only need a minor disappointment this week as the earnings season kicks in for there to be downside risk for equity investors."
© Dukascopy Bank